Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Alcresta Therapeutics logo — Fulfilling potential: With the Science of Enzymes

Alcresta Therapeutics

Fulfilling potential: With the Science of Enzymes

Founded 2011 United States Newton, United States 77 employees Series Unknown Biotechnology, Health Care +1

General Information

Company Name Alcresta Therapeutics
Founded Year 2011
Location United States Newton, United States +1
Employees 77
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series Unknown
Social

Get notified when Alcresta Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Alcresta Therapeutics

Alcresta Therapeutics is a biotechnology company founded in 2011 and headquartered in the United States. The company focuses on developing and commercializing enzyme-based products to address challenges faced by individuals with gastrointestinal disorders and rare diseases. Their proprietary technology platform supports a pipeline of products designed to tackle pancreatic insufficiency and fat malabsorption prevalent in conditions such as cystic fibrosis, digestive cancers, and preterm birth. Their lead product, RELiZORB®, is targeted at enhancing the breakdown and absorption of fats, particularly long-chain polyunsaturated fatty acids. The company has garnered support from renowned venture investors including Athyrium Capital Management, Bessemer Venture Partners, Frazier Healthcare, and Third Rock Ventures. With a focus on the medical devices and health care industries, Alcresta Therapeutics aims to leverage its extensive experience in pharmaceutical, medical device, and nutritional product development to bring innovative solutions to the market.

No funding data available for Alcresta Therapeutics yet.

Get notified when Alcresta Therapeutics raises funding

Alcresta Therapeutics Alternatives & Competitors

Alcresta Therapeutics vs
Fresenius Kabi USA
Fresenius Kabi USA United States

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technol...

1792 employees
Alcresta Therapeutics vs
CUBIQ FOODS
CUBIQ FOODS Spain

Go!Drop and Go!Mega3 platforms lead in sustainable tasty and clean nutritional profiles for key food...

Unknown
9 employees
Biotechnology, Food and Beverage
Compare Alcresta Therapeutics vs CUBIQ FOODS
Alcresta Therapeutics vs
Yali Bio
Yali Bio United States

designer fats for better foods and nutrition.

Seed
9 employees
Biotechnology, Food and Beverage
Compare Alcresta Therapeutics vs Yali Bio
Also compare with: Alcresta Therapeutics vs Profectus BioSciences, Inc Profectus BioSciences, Inc

FAQ About Alcresta Therapeutics

Fulfilling potential: With the Science of Enzymes
Alcresta Therapeutics was founded in 2011.
Alcresta Therapeutics is headquartered in Newton, United States.
Alcresta Therapeutics operates in the following industries: Biotechnology, Health Care, Medical Devices.
Alcresta Therapeutics has approximately 77 employees.
Top alternatives and competitors to Alcresta Therapeutics include Fresenius Kabi USA, CUBIQ FOODS, Yali Bio, Profectus BioSciences, Inc, Annexon Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alcresta Therapeutics and Fresenius Kabi USA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Alcresta Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy